RSS | Login | Register

CHILDREN'S ZYRTEC ALLERGY SYRUP

Compare to Similar Drugs | Add to Clipboard | View Clipboard | Print | Email

Close [X]

Compare CHILDREN'S ZYRTEC ALLERGY SYRUP to:

Generic Name for CHILDREN'S ZYRTEC ALLERGY SYRUP

Cetirizine HCl 1mg/mL; grape flavor, and bubble gum (sugar- and dye-free) flavor.

Legal Classification:

OTC

Pharmacological Class for CHILDREN'S ZYRTEC ALLERGY SYRUP

Antihistamine.

Manufacturer of CHILDREN'S ZYRTEC ALLERGY SYRUP

McNeil Consumer & Specialty Pharmaceuticals

Indications for CHILDREN'S ZYRTEC ALLERGY SYRUP

Allergic rhinitis.

Adults and Children:

Chew tabs: may take with or without water. For doses <5mg: use syrup. <2years: not recommended. 2–6years: initially 2.5mg once daily; max 5mg once daily or 2.5mg every 12 hours. ≥6years: initially 5–10mg once daily. ≥65years: use chew tabs or syrup: 5mg once daily. Hepatic or renal impairment: individualize.

Also:

CHILDREN'S ZYRTEC CHEWABLE

CHILDREN'S ZYRTEC HIVES RELIEF SYRUP

CHILDREN'S ZYRTEC PERFECT MEASURE

ZYRTEC

ZYRTEC HIVES RELIEF

ZYRTEC LIQUID GELS

Contraindications for CHILDREN'S ZYRTEC ALLERGY SYRUP

Hydroxyzine sensitivity.

Warnings/Precautions for CHILDREN'S ZYRTEC ALLERGY SYRUP

Hives Relief: not used for prevention or as a substitute for epinephrine. Hepatic or renal dysfunction. Pregnancy. Nursing mothers: not recommended.

Interactions for CHILDREN'S ZYRTEC ALLERGY SYRUP

Potentiates CNS depression with alcohol, other CNS depressants.

Adverse Reactions for CHILDREN'S ZYRTEC ALLERGY SYRUP

Drowsiness, somnolence, fatigue, dry mouth, pharyngitis. Children: headache, pharyngitis, GI upset/pain, cough, somnolence, diarrhea, epistaxis, bronchospasm, fatigue, irritability, insomnia.

How is CHILDREN'S ZYRTEC ALLERGY SYRUP supplied?

Tabs—5, 14, 30, 45, 75
Liquid gels—12, 25, 40
Chew tabs 5mg—5
10mg—12, 24
Prefilled spoons (5mL)—10
Hives Relief tabs—14
Syrups—4oz

Related Disease:

Allergic rhinitis~systemic products

Allergy~systemic antiallergic drugs

Urticaria~antihistamines

McNeil Consumer Healthcare product supply update

June 25, 2010

McNeil Consumer Healthcare announced that it does not anticipate having sources of supply for most of the products that were produced at its Fort Washington, Pennsylvania manufacturing facility before the end of 2010.

Vicks Sinex VapoSpray 4-Hour Decongestant Nasal Spray recalled

June 24, 2010

Procter & Gamble announced a voluntary nationwide recall of Vicks Sinex VapoSpray 4-Hour Decongestant Nasal Spray (oxymetazoline HCl).

McNeil recalls Benadryl Allergy Ultratab and Extra Strength Tylenol Rapid Release Gels

June 16, 2010

McNeil Consumer Healthcare has expanded its January 15, 2010 recall to include four lots of Benadryl Allergy (diphenhydramine) Ultratab Tablets and one lot of Extra Strength Tylenol (acetaminophen) Rapid Release Gels.

FDA warns against swallowing topical Benadryl gel

May 12, 2010

The FDA is warning consumers about potentially serious side effects from mistakenly swallowing McNeil Consumer & Specialty Pharmaceuticals' Benadryl (diphenhydramine) Extra Strength Itch Stopping Gel.

FDA launches "Bad Ad Program" to detect misleading drug ads

May 11, 2010

The FDA's Division of Drug Marketing, Advertising, and Communications (DDMAC) has launched the Bad Ad Program, designed to educate healthcare providers about their role in ensuring that prescription drug advertising and promotion is truthful, and not misleading.